peptide tirzepatide dosage 💊 — Mechanism of Action & Pharmacokinetics 👨‍⚕️ Mechanism of Action • Tirzepatide is the first dual GIP/GLP-1 receptor agonist. • Activates both: - Glucose-Dependent Insulinotropic Polypeptide (GIP) receptors Tirzepatide: Dosing & Research Guide

Lalosevic J et al

Interestingly, the VTA proved to be the key target site for food intake and reward effect of leptin

Zhou, W., Liu, W., Zou, L., Liu, W., Liu, C., Liang, R., & Chen, J

Gastrointestinal effects predominate: | Side Effect | Orforglipron | Oral Semaglutide | Tirzepatide | |-------------|-------------|-----------------|-------------| | **Nausea** | 22-28% | 24-28% | 24-31% | | **Vomiting** | 8-12% | 10-14% | 9-13% | | **Diarrhea** | 14-18% | 12-16% | 14-21% | | **Constipation** | 10-14% | 8-12% | 11-15% | | **Dyspepsia** | 6-9% | 8-11% | 5-8% | | **Discontinuation due to AEs** | ~6-8% | ~7-9% | ~4-7% | A notable difference: oral semaglutide has higher rates of upper GI symptoms (reflux, dyspepsia) because the SNAC formulation makes direct contact with gastric mucosa

On the free radical scavenging activities of melatonins metabolites, Afmk and Amk

Am J Physiol 255:H12691275 Gu F, Chauhan V, Chauhan A (2013a) Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes